Literature DB >> 30201191

Hepatitis B: From control to cure.

Jia-Horng Kao1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30201191     DOI： 10.1016/j.jfma.2018.08.020

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN： 0929-6646            Impact factor:   3.282


× No keyword cloud information.
  3 in total

1.  Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients.

Authors:  Huei-Ru Cheng; Hung-Chih Yang; Su-Ru Lin; Ta-Yu Yang; You-Yu Lin; Tung-Hung Su; Tai-Chung Tseng; Chun-Jen Liu; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2021-04-22       Impact factor: 6.047

2.  Progress towards elimination goals for viral hepatitis.

Authors:  Andrea L Cox; Manal H El-Sayed; Jia-Horng Kao; Jeffrey V Lazarus; Maud Lemoine; Anna S Lok; Fabien Zoulim
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-07-23       Impact factor: 46.802

3.  Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy.

Authors:  Tai-Chung Tseng; Cheng-Yuan Peng; Yao-Chun Hsu; Tung-Hung Su; Chia-Chi Wang; Chun-Jen Liu; Hung-Chih Yang; Wan-Ting Yang; Chia-Hsin Lin; Ming-Lung Yu; Hsueh-Chou Lai; Yasuhito Tanaka; Mindie H Nguyen; Chen-Hua Liu; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Liver Cancer       Date:  2020-01-10       Impact factor: 11.740
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.